Sandoz Korea announced on the 29th that it signed an exclusive sales partnership with Ilsung on the 28th with muscle relaxation antagonist Sandoz Sugammedex Sodium. According to the agreement, the two companies will start supplying and selling Sandoz Sugamadex on the 13th of next month. The two companies expected that Ilsung's sales know-how, with its superior quality of Sandoz Sugarmadex Sodium, would create synergy. Sandoz Sugarmadex is a muscle relaxation antagonist that was approved by the MFDS in January. It exhibits a reversal effect of neuromuscular blocking induced by Rocuronium or Vecuronium, a systemic anesthetic ingredient.

Sandoz carried out the entire production process in Europe, from raw